vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $47.7M, roughly 1.6× IRONWOOD PHARMACEUTICALS INC). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -4.8%, a 13.4% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs -47.3%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs -20.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BFS vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $47.7M |
| Net Profit | $6.5M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 65.4% | 14.3% |
| Net Margin | 8.7% | -4.8% |
| Revenue YoY | 10.6% | -47.3% |
| Net Profit YoY | -19.6% | -200.9% |
| EPS (diluted) | $0.15 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $47.7M | ||
| Q3 25 | $72.0M | $122.1M | ||
| Q2 25 | $70.8M | $85.2M | ||
| Q1 25 | $71.9M | $41.1M | ||
| Q4 24 | $67.9M | $90.5M | ||
| Q3 24 | $67.3M | $91.6M | ||
| Q2 24 | $66.9M | $94.4M | ||
| Q1 24 | $66.7M | $74.9M |
| Q4 25 | $6.5M | $-2.3M | ||
| Q3 25 | $10.5M | $40.1M | ||
| Q2 25 | $10.7M | $23.6M | ||
| Q1 25 | $9.8M | $-37.4M | ||
| Q4 24 | $8.1M | $2.3M | ||
| Q3 24 | $14.5M | $3.6M | ||
| Q2 24 | $14.4M | $-860.0K | ||
| Q1 24 | $13.6M | $-4.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | 65.4% | 14.3% | ||
| Q3 25 | 69.1% | 61.8% | ||
| Q2 25 | 68.7% | 53.2% | ||
| Q1 25 | 66.5% | -70.7% | ||
| Q4 24 | 82.9% | 34.8% | ||
| Q3 24 | 72.8% | 28.0% | ||
| Q2 24 | 75.0% | 26.5% | ||
| Q1 24 | 72.4% | 14.7% |
| Q4 25 | 8.7% | -4.8% | ||
| Q3 25 | 14.6% | 32.8% | ||
| Q2 25 | 15.1% | 27.7% | ||
| Q1 25 | 13.6% | -90.9% | ||
| Q4 24 | 11.9% | 2.5% | ||
| Q3 24 | 21.5% | 4.0% | ||
| Q2 24 | 21.6% | -0.9% | ||
| Q1 24 | 20.4% | -5.6% |
| Q4 25 | $0.15 | $0.01 | ||
| Q3 25 | $0.32 | $0.23 | ||
| Q2 25 | $0.33 | $0.14 | ||
| Q1 25 | $0.29 | $-0.23 | ||
| Q4 24 | $0.22 | $0.03 | ||
| Q3 24 | $0.48 | $0.02 | ||
| Q2 24 | $0.48 | $-0.01 | ||
| Q1 24 | $0.45 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $215.5M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $-261.8M |
| Total Assets | $2.2B | $396.9M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $215.5M | ||
| Q3 25 | $11.8M | $140.4M | ||
| Q2 25 | $5.3M | $92.9M | ||
| Q1 25 | $6.5M | $108.5M | ||
| Q4 24 | $10.3M | $88.6M | ||
| Q3 24 | $7.2M | $88.2M | ||
| Q2 24 | $6.9M | $105.5M | ||
| Q1 24 | $7.1M | $121.5M |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | $199.5M | ||
| Q2 25 | $1.6B | $199.3M | ||
| Q1 25 | $1.5B | $199.2M | ||
| Q4 24 | $455.8M | $199.0M | ||
| Q3 24 | $1.5B | $198.8M | ||
| Q2 24 | $1.4B | $198.6M | ||
| Q1 24 | $1.4B | $398.3M |
| Q4 25 | $307.8M | $-261.8M | ||
| Q3 25 | $316.6M | $-264.2M | ||
| Q2 25 | $322.4M | $-308.2M | ||
| Q1 25 | $328.4M | $-334.1M | ||
| Q4 24 | $335.8M | $-301.3M | ||
| Q3 24 | $341.8M | $-311.3M | ||
| Q2 24 | $345.7M | $-321.7M | ||
| Q1 24 | $347.1M | $-330.5M |
| Q4 25 | $2.2B | $396.9M | ||
| Q3 25 | $2.2B | $396.1M | ||
| Q2 25 | $2.1B | $342.9M | ||
| Q1 25 | $2.1B | $327.2M | ||
| Q4 24 | $2.1B | $350.9M | ||
| Q3 24 | $2.1B | $389.5M | ||
| Q2 24 | $2.1B | $395.6M | ||
| Q1 24 | $2.0B | $438.8M |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $74.6M | ||
| Q3 25 | $20.6M | $47.6M | ||
| Q2 25 | $26.6M | $-15.1M | ||
| Q1 25 | $30.4M | $20.0M | ||
| Q4 24 | $121.2M | $15.2M | ||
| Q3 24 | $26.5M | $9.9M | ||
| Q2 24 | $32.1M | $33.5M | ||
| Q1 24 | $33.8M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-28.3M | $9.9M | ||
| Q2 24 | $-12.5M | $33.4M | ||
| Q1 24 | $-11.7M | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -42.1% | 10.8% | ||
| Q2 24 | -18.7% | 35.4% | ||
| Q1 24 | -17.6% | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 81.5% | 0.0% | ||
| Q2 24 | 66.7% | 0.1% | ||
| Q1 24 | 68.3% | 0.1% |
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | 1.19× | ||
| Q2 25 | 2.48× | -0.64× | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | 6.74× | ||
| Q3 24 | 1.83× | 2.71× | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
